BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23815535)

  • 1. Effects of nebivolol on aortic compliance in patients with diabetes and maximal renin angiotensin system blockade: the EFFORT study.
    Briasoulis A; Oliva R; Kalaitzidis R; Flynn C; Lazich I; Schlaffer C; Bakris G
    J Clin Hypertens (Greenwich); 2013 Jul; 15(7):473-9. PubMed ID: 23815535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
    Weiss RJ; Stapff M; Lin Y
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness.
    Kampus P; Serg M; Kals J; Zagura M; Muda P; Karu K; Zilmer M; Eha J
    Hypertension; 2011 Jun; 57(6):1122-8. PubMed ID: 21536983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of difference between nebivolol/hydrochlorothiazide and metoprolol/hydrochlorothiazide on aortic wave augmentation and central blood pressure.
    Eeftinck Schattenkerk DW; van den Bogaard B; Cammenga M; Westerhof BE; Stroes ES; van den Born BJ
    J Hypertens; 2013 Dec; 31(12):2447-54. PubMed ID: 24126713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of left ventricular diastolic function induced by β-blockade: a comparison between nebivolol and metoprolol.
    Fang Y; Nicol L; Harouki N; Monteil C; Wecker D; Debunne M; Bauer F; Lallemand F; Richard V; Thuillez C; Mulder P
    J Mol Cell Cardiol; 2011 Aug; 51(2):168-76. PubMed ID: 21640121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial.
    Wright JT; Bakris GL; Bell DS; Fonseca V; Katholi RE; McGill JB; Messerli FH; Phillips RA; Raskin P; Holdbrook FK; Lukas MA; Iyengar M
    J Clin Hypertens (Greenwich); 2007 Nov; 9(11):842-9. PubMed ID: 17978591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men.
    Brixius K; Middeke M; Lichtenthal A; Jahn E; Schwinger RH
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):327-31. PubMed ID: 17324145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the efficacy and tolerability of nebivolol versus lisinopril in the treatment of essential arterial hypertension: a randomized, multicentre, double-blind study.
    Rosei EA; Rizzoni D; Comini S; Boari G;
    Blood Press Suppl; 2003 May; 1():30-5. PubMed ID: 12800985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection.
    Mahmud A; Feely J
    Am J Hypertens; 2008 Jun; 21(6):663-7. PubMed ID: 18437130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of low-dose carvedilol, nebivolol, and metoprolol on central arterial pressure and its determinants: a randomized clinical trial.
    Studinger P; Tabák ÁG; Chen CH; Salvi P; Othmane TE; Torzsa P; Kapocsi J; Fekete BC; Tislér A
    J Clin Hypertens (Greenwich); 2013 Dec; 15(12):910-7. PubMed ID: 24119182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central hemodynamics in prehypertension: effect of the β-adrenergic antagonist nebivolol.
    Davis JT; Pasha DN; Khandrika S; Fung MM; Milic M; O'Connor DT
    J Clin Hypertens (Greenwich); 2013 Jan; 15(1):69-74. PubMed ID: 23282127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure effects of combined β-blocker and angiotensin-converting enzyme inhibitor therapy compared with the individual agents: a placebo-controlled study with nebivolol and lisinopril.
    Weber MA; Basile J; Stapff M; Khan B; Zhou D
    J Clin Hypertens (Greenwich); 2012 Sep; 14(9):588-92. PubMed ID: 22947356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Blockers in patients with intermittent claudication and arterial hypertension: results from the nebivolol or metoprolol in arterial occlusive disease trial.
    Espinola-Klein C; Weisser G; Jagodzinski A; Savvidis S; Warnholtz A; Ostad MA; Gori T; Munzel T
    Hypertension; 2011 Aug; 58(2):148-54. PubMed ID: 21646599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension.
    Perros F; Ranchoux B; Izikki M; Bentebbal S; Happé C; Antigny F; Jourdon P; Dorfmüller P; Lecerf F; Fadel E; Simonneau G; Humbert M; Bogaard HJ; Eddahibi S
    J Am Coll Cardiol; 2015 Feb; 65(7):668-80. PubMed ID: 25677428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nebivolol monotherapy in younger adults (younger than 55 years) with hypertension: a randomized, placebo-controlled trial.
    Giles TD; Khan BV; Lato J; Brener L; Ma Y; Lukic T
    J Clin Hypertens (Greenwich); 2013 Sep; 15(9):687-93. PubMed ID: 24034663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nebivolol versus metoprolol on sodium sensitivity and renal sodium handling in hypertensive Hispanic postmenopausal women.
    Preston RA; Afshartous D; Materson BJ; Rodco R; Alonso AB
    Hypertension; 2014 Aug; 64(2):287-95. PubMed ID: 24842917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release.
    Kamp O; Metra M; Bugatti S; Bettari L; Dei Cas A; Petrini N; Dei Cas L
    Drugs; 2010; 70(1):41-56. PubMed ID: 20030424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nebivolol and valsartan as a fixed-dose combination for the treatment of hypertension.
    Sander GE; Giles TD
    Expert Opin Pharmacother; 2015 Apr; 16(5):763-70. PubMed ID: 25747524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: a pharmacoeconomic comparison of antihypertensive efficacy of beta blockers.
    Patel RS; Sharma KH; Kamath NA; Patel NH; Thakkar AM
    Indian J Pharmacol; 2014; 46(5):485-9. PubMed ID: 25298575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of beta-blockers on sleep in patients with mild hypertension: a randomized trial between nebivolol and metoprolol.
    Yilmaz MB; Erdem A; Yalta K; Turgut OO; Yilmaz A; Tandogan I
    Adv Ther; 2008 Sep; 25(9):871-83. PubMed ID: 18758699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.